Literature DB >> 34930802

Obstructive sleep apnea confers lower mortality risk in acute ischemic stroke patients treated with endovascular thrombectomy: National Inpatient Sample analysis 2010-2018.

Justin M Lapow1, Alis J Dicpinigaitis1, Rajkumar S Pammal1, Griffin A Coghill1, Osher Rechester2, Eric Feldstein3, Rolla Nuoman4, Kristina Maselli2, Shyla Kodi1,2, Andrew Bauerschmidt5, Jon B Rosenberg5, Shadi Yaghi6, Gurmeen Kaur7, Christeen Kurian4, Ji Y Chong4,7, Stephan A Mayer4, Chirag D Gandhi7, Fawaz Al-Mufti8.   

Abstract

BackgroundObstructive sleep apnea (OSA) portends increased morbidity and mortality following acute ischemic stroke (AIS). Evaluation of OSA in the setting of AIS treated with endovascular mechanical thrombectomy (MT) has not yet been evaluated in the literature.
METHODS: The National Inpatient Sample from 2010 to 2018 was utilized to identify adult AIS patients treated with MT. Those with and without OSA were compared for clinical characteristics, complications, and discharge disposition. Multivariable logistic regression analysis and propensity score adjustment (PA) were employed to evaluate independent associations between OSA and clinical outcome.
RESULTS: Among 101 093 AIS patients treated with MT, 6412 (6%) had OSA. Those without OSA were older (68.5 vs 65.6 years old, p<0.001), female (50.5% vs 33.5%, p<0.001), and non-caucasian (29.7% vs 23.7%, p<0.001). The OSA group had significantly higher rates of obesity (41.4% vs 10.5%, p<0.001), atrial fibrillation (47.1% vs 42.2%, p=0.001), hypertension (87.4% vs 78.5%, p<0.001), and diabetes mellitus (41.2% vs 26.9%, p<0.001). OSA patients treated with MT demonstrated lower rates of intracranial hemorrhage (19.1% vs 21.8%, p=0.017), treatment of hydrocephalus (0.3% vs 1.1%, p=0.009), and in-hospital mortality (9.7% vs 13.5%, p<0.001). OSA was independently associated with lower rate of in-hospital mortality (aOR 0.76, 95% CI 0.69 to 0.83; p<0.001), intracranial hemorrhage (aOR 0.88, 95% CI 0.83 to 0.95; p<0.001), and hydrocephalus (aOR 0.51, 95% CI 0.37 to 0.71; p<0.001). Results were confirmed by PA.
CONCLUSIONS: Our findings suggest that MT is a viable and safe treatment option for AIS patients with OSA. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  stroke; thrombectomy

Year:  2021        PMID: 34930802     DOI: 10.1136/neurintsurg-2021-018161

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  1 in total

1.  Cardiac arrhythmias and mortality risk among patients with obstructive sleep apnea following admission for acute myocardial infarction or acute ischemic stroke.

Authors:  Kamleshun Ramphul; Petras Lohana; Renuka Verma; Nomesh Kumar; Yogeshwaree Ramphul; Arti Lohana; Shaheen Sombans; Stephanie Gonzalez Mejias; Komal Kumari
Journal:  Arch Med Sci Atheroscler Dis       Date:  2022-08-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.